Ectopic Pregnancy Market Report 2026

Ectopic Pregnancy Market Overview

• Ectopic Pregnancy market size has reached to $8.6 billion in 2025 • Expected to grow to $11.31 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: The Increasing Use of Contraceptive Devices Fueling Market Growth Due to Rising Family Planning Needs and Unintended Pregnancy Prevention • Market Trend: AI-Powered Ultrasound Systems Revolutionize Ectopic Pregnancy Diagnosis • North America was the largest region in 2025.

What Is Covered Under Ectopic Pregnancy Market?

Ectopic pregnancy is a medical condition where a fertilized egg implants and develops outside the uterus, typically in the fallopian tubes, posing significant risks if not identified and managed promptly. This condition is dangerous and requires medical attention, as the embryo cannot develop normally outside the uterus and can cause life-threatening complications such as rupture and internal bleeding if left untreated. The main types of ectopic pregnancy are tubal ectopic pregnancy, non-tubal ectopic pregnancy, heterotopic ectopic pregnancy, and others. A tubal ectopic pregnancy develops when a fertilized egg implanted and began to grow within the fallopian tubes, which transfer eggs from the ovaries to the uterus. The treatments, such as folic acid analogues and corticosteroids, are distributed through various channels, including retail, online, and hospital pharmacies, catering to hospitals, clinics, fertility centers, and other end-users.

What Is The Ectopic Pregnancy Market Growth Forecast?

The ectopic pregnancy market size is expected to see strong growth in the next few years. It will grow to $11.31 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to early screening programs, minimally invasive treatments, reproductive health awareness, fertility clinic expansion, tele-gynecology services. Major trends in the forecast period include rising adoption of early diagnostic imaging, increased use of non-surgical medical management, growing awareness of early pregnancy complications, expansion of emergency gynecological care, improved access to fertility and reproductive health services.

Global Ectopic Pregnancy Market Segmentation

1) By Type: Tubal Ectopic Pregnancy, Non-Tubal Ectopic Pregnancy, Heterotopic Ectopic Pregnancy, Other Types 2) By Treatment: Folic Acid Analogue, Corticosteroid, Other Treatments 3) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, Other Distribution Channels 4) By End-User: Hospitals, Clinics, Fertility Centers, Other End-Users Subsegments: 1) By Tubal Ectopic Pregnancy: Ampullary Ectopic Pregnancy, Isthmic Ectopic Pregnancy, Fimbrial Ectopic Pregnancy, Interstitial Ectopic Pregnancy 2) By Non-Tubal Ectopic Pregnancy: Ovarian Ectopic Pregnancy, Cervical Ectopic Pregnancy, Abdominal Ectopic Pregnancy, Caesarean Scar Ectopic Pregnancy 3) By Heterotopic Ectopic Pregnancy: Single Gestation With Ectopic Pregnancy, Multiple Gestation With Ectopic Pregnancy 4) By Other Types: Cornual Ectopic Pregnancy, Rudimentary Horn Pregnancy

What Are The Drivers Of The Ectopic Pregnancy Market?

The increasing use of contraceptive devices is expected to propel the growth of the ectopic pregnancy market going forward. Contraceptive devices are tools designed to prevent pregnancy by blocking fertilization or the implantation of a fertilized egg, and their adoption is rising due to growing emphasis on family planning, population management, and the prevention of unintended pregnancies. The higher uptake of these devices, particularly intrauterine devices (IUDs), can unintentionally increase the risk of ectopic pregnancy if conception occurs, as IUDs may alter the normal movement of the egg through the fallopian tubes, potentially leading to implantation outside the uterus. For instance, in February 2024, according to the Faculty of Sexual and Reproductive Healthcare (FSRH), a UK-based organization for family planning and sexual health, from 2022 to 2023, the utilization of long-acting reversible contraceptives (LARC) rose to 44.1 per 1,000 people, up from 41.8 per 1,000 Therefore, the increasing use of contraceptive devices is driving the growth of the ectopic pregnancy industry. The increasing maternal age and delayed pregnancies are expected to propel the growth of the ectopic pregnancy market going forward. Maternal age and delayed pregnancies refer to women choosing to have children later in life, which naturally increases the health risks associated with pregnancy, including the chances of complications such as ectopic pregnancy. Maternal age and delayed pregnancies are rising because many women are prioritizing career and financial stability before starting a family, leading them to plan pregnancies later in life as they aim for a more secure future. Ectopic pregnancy highlights the increased medical risks associated with conceiving at an older age, reinforcing the need for timely monitoring and care in populations where maternal age and delayed pregnancies are becoming more common. For instance, in July 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, the birth rate for women ages 40–44 increased 2% from 12.5 per 1,000 in 2023 to 12.7 per 1,000 in 2024. Therefore, the increasing maternal age and delayed pregnancies are driving the growth of the ectopic pregnancy industry.

Key Players In The Global Ectopic Pregnancy Market

Major companies operating in the ectopic pregnancy market are Pfizer Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Fresenius Kabi USA, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, H. Lundbeck A/S, Dr. Reddy's Laboratories, Hikma Pharmaceuticals Plc, Lupin Pharmaceuticals Inc., Zydus Pharmaceuticals

Global Ectopic Pregnancy Market Trends and Insights

Major companies operating in the ectopic pregnancy market are developing artificial intelligence (AI)-powered ultrasound systems to enhance diagnostic accuracy and improve patient outcomes. AI-powered ultrasound systems use machine learning algorithms to analyze ultrasound images, enhancing the accuracy and speed of ectopic pregnancy diagnosis. For instance, in April 2024, GE HealthCare, a US-based medical technology and diagnostics company, launched the Voluson Signature 20 and 18 ultrasound systems, featuring a complete integration of artificial intelligence (AI), enhanced tools, and an ergonomic design to reduce exam duration for clinicians while providing clearer insights into women's health conditions. These advanced systems merge high-performance hardware with adaptable, scalable software, aimed at boosting clinicians' confidence in their diagnostic and treatment decisions.

Regional Outlook

North America was the largest region in the ectopic pregnancy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ectopic Pregnancy Market?

The ectopic pregnancy market consists of revenues earned by entities by providing services such as diagnostic services, emergency medical services, surgical services, and pharmacological treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ectopic pregnancy market also includes sales of ultrasound machines, hormone level monitoring kits, and medications such as methotrexate for medical management. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ectopic Pregnancy Market Report 2026?

The ectopic pregnancy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ectopic pregnancy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.